Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.60 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.60 |
| ▸ | USP2 | O75604 | 1/20 | 0.60 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.60 |
| ▸ | LMNA | P02545 | 3/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.46 |
| ▸ | ACHE | P22303 | 1/20 | 0.46 |
| ▸ | APEX1 | P27695 | 1/20 | 0.46 |
| ▸ | RECQL | P46063 | 1/20 | 0.46 |
| ▸ | BLM | P54132 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | SAE1 | Q9UBE0 | 1/20 | 0.46 |
| ▸ | UBA2 | Q9UBT2 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29517121 | 0.98 | ALDH1A1 (0.63) | ALDH1A1TDP1USP2ALOX15LMNA | |
| SCHEMBL4558351 | 0.98 | ALDH1A1 (0.63) | ALDH1A1TDP1USP2ALOX15LMNA | |
| Chaulmoogric Acid SCHEMBL560848 | 0.98 | ALDH1A1 (0.63) | ALDH1A1TDP1USP2ALOX15LMNA | |
| SCHEMBL580439 | 0.98 | ALDH1A1 (0.63) | ALDH1A1TDP1USP2ALOX15LMNA | |
| Chaulmoogric Acid SCHEMBL560849 | 0.98 | ALDH1A1 (0.63) | ALDH1A1TDP1USP2ALOX15LMNA | |
| SCHEMBL2491883 | 0.98 | ALDH1A1 (0.63) | ALDH1A1TDP1USP2ALOX15LMNA | |
| Chaulmoogric Acid SCHEMBL560850 | 0.98 | ALDH1A1 (0.63) | ALDH1A1TDP1USP2ALOX15LMNA | |
| SCHEMBL2494531 | 0.98 | ALDH1A1 (0.63) | ALDH1A1TDP1USP2ALOX15LMNA | |
| SCHEMBL580438 | 0.98 | ALDH1A1 (0.63) | ALDH1A1TDP1USP2ALOX15LMNA | |
| SCHEMBL14706726 | 0.94 | ALDH1A1 (0.54) | ALDH1A1TDP1USP2ALOX15LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4692226-A1 | SOLUTION, DISPERSANT, METHOD FOR PRODUCING VINYL COMPOUND POLYMER, AND METHOD FOR PRODUCING SOLUTION | Kuraray Co., Ltd. (JP) | 2026-02-11 | — | — | EP | disclosed |
| EP-4674910-A1 | COMPOSITION COMPRISING VINYL ALCOHOL-BASED POLYMER, AND METHOD FOR SEPARATING VINYL ALCOHOL-BASED POLYMER | Kuraray Co., Ltd. (JP) | 2026-01-07 | — | — | EP | disclosed |
| US-20200155575-A1 | PHARMACEUTICAL COMPOSITION AND METHODS | LIPOCINE INC. (US) | 2020-05-21 | — | — | US | disclosed |
| US-20190269700-A1 | PHARMACEUTICAL COMPOSITION AND METHODS | LIPOCINE INC. (US) | 2019-09-05 | — | — | US | disclosed |
| US-20180104257-A1 | (17-ß)-3-Oxoandrost-4-En-17-Yl Undecanoate Compositions and Methods of Their Preparation and Use | LIPOCINE INC. (US) | 2018-04-19 | — | — | US | disclosed |
| US-20180078568-A1 | PHARMACEUTICAL COMPOSITION AND METHODS | LIPOCINE INC. (US) | 2018-03-22 | — | — | US | disclosed |
| CN-106999502-A | Pharmaceutical composition and method | 来普卡公司 | 2017-08-01 | — | — | CN | disclosed |
| CN-106999558-A | Base undecylate composition of (17 β) 3 oxygen androstane-14 alkene 17 and its production and use | 来普卡公司 | 2017-08-01 | — | — | CN | disclosed |
| EP-3185873-A1 | PHARMACEUTICAL COMPOSITION AND METHODS | Lipocine Inc. (US) | 2017-07-05 | — | — | EP | disclosed |
| US-20160193225-A1 | (17-ß)-3-OXOANDROST-4-EN-17-YL UNDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE | LIPOCINE INC. (US) | 2016-07-07 | — | — | US | disclosed |
| US-20160184324-A1 | PHARMACEUTICAL COMPOSITION AND METHODS | LIPOCINE INC. (US) | 2016-06-30 | — | — | US | disclosed |
| WO-2016033536-A1 | PHARMACEUTICAL COMPOSITION AND METHODS | LIPOCINE INC. (US) | 2016-03-03 | — | — | WO | disclosed |
| WO-2016033611-A1 | (17-β)-3-OXOANDROST-4-EN-17-YL UNDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE | LIPOCINE INC. (US) | 2016-03-03 | — | — | WO | disclosed |